Ocular Therapeutix to hold a conference call
Management holds a conference call to discuss the FDA approval of DEXTENZA for treatment of ocular pain following ophthalmic surgery on December 3 at 8:30 am.https://thefly.com/landingPageNews.php?id=2831101
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.